Back to KLOW (BPC-157 + GHK-Cu + TB-500 + KPV) profile
KLOW (BPC-157 + GHK-Cu + TB-500 + KPV) dosage chart
Studied dosing of KLOW (BPC-157 + GHK-Cu + TB-500 + KPV) and a units conversion chart for common vial sizes.
Studied dosing
- Dose in studies
- 2 mg. Can Vary by formulation – dose based on total vial content and supplier guidelines
- Frequency
- Daily subcutaneous injection (per supplier protocol)
- Cycle length
- 12-16 weeks on, 4-6 weeks off. Can extend under medical supervision for chronic conditions.
- Half-life
- Blend half-life varies by component (1-4 hours). Designed for once-daily injection as a pre-mixed formulation.
Values from research literature – not medical advice.
Units per dose (U-100 syringe)
Units (IU) matching the dose on a U-100 insulin syringe (100 units = 1 ml). Formula: dose (mg) ÷ (vial mg ÷ water ml) × 100.
| Dose | 5 mg / 2 ml | 10 mg / 2 ml | 10 mg / 3 ml | 20 mg / 2 ml |
|---|---|---|---|---|
| 100 mcg | 4 IU | 2 IU | 3 IU | 1 IU |
| 250 mcg | 10 IU | 5 IU | 7.5 IU | 2.5 IU |
| 500 mcg | 20 IU | 10 IU | 15 IU | 5 IU |
| 1 mg | 40 IU | 20 IU | 30 IU | 10 IU |
| 2 mg | 80 IU | 40 IU | 60 IU | 20 IU |
| 2.5 mg | 100 IU | 50 IU | 75 IU | 25 IU |
| 5 mg | – | 100 IU | – | 50 IU |
| 7.5 mg | – | – | – | 75 IU |
| 10 mg | – | – | – | 100 IU |
– = does not fit a 1 ml syringe or exceeds the vial content.